s6y
Company name or ticker
Search
Akebia Therapeutics, Inc.
3
Vickers Philip J.: Initial statement of beneficial ownership of securities
Filed
Friday, April 3, 2026
Period
Apr 1, 2026
Accession number
0001635046-26-000004
Documents
PRIMARY DOCUMENT
3
POA
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header